Results 51 to 60 of about 3,391 (207)
Treatment approaches in posthypoxic myoclonus: A narrative review with expert opinion
Abstract Acute posthypoxic myoclonus (PHM) is a neurological complication that typically emerges within 12–48 h following cardiac arrest, often in comatose patients. It can present as generalized, multifocal, or focal myoclonus and has traditionally been associated with poor prognosis.
Marina Romozzi +7 more
wiley +1 more source
Piracetam Co-Crystals with OH-Group Functionalized Carboxylic Acids
We report the synthesis, crystal structures, and basic physicochemical properties of six co-crystals of piracetam. Co-crystals of piracetam with l-tartaric acid, with citric acid in a 1:1 and 3:2 ratio, with racemic mandelic acid, and with l-mandelic ...
Fritz Blatter (2376541) +3 more
core +1 more source
The mitochondrial cascade hypothesis of dementia assumes mitochondrial dysfunction leading to reduced energy supply, impaired neuroplasticity, and finally cell death as one major pathomechanism underlying the continuum from brain aging over mild ...
Carola Stockburger +4 more
doaj +1 more source
Epilepsy in dentatorubral–pallidoluysian atrophy: A systematic review and meta‐analysis
Summary of key clinical and electrophysiological characteristics of DRPLA‐related epilepsy from a systematic review and meta‐analysis of 1,191 patients. DRPLA patients with epilepsy showed earlier disease onset, longer CAG repeat expansion, and a tendency toward paternal inheritance. EEG findings frequently included photoparoxysmal responses.
Toru Horinouchi +10 more
wiley +1 more source
POSSIBILITIES TO USE A FIXED COMBINATION OF PIRACETAM AND CINNARIZINE IN NEUROLOGICAL PRACTICE
The article discusses the possibility of using the complex drug Phezam, containing 400 mg of Piracetam and 25 mg of Cinnarizine in neurological practice.
N. V. Titova
doaj +1 more source
Piracetam for acute ischaemic stroke [PDF]
Piracetam has neuroprotective and antithrombotic effects which may help to reduce death and disability in people with acute stroke.The objective of this review was to assess the effects of piracetam in acute presumed ischaemic stroke.We searched the Cochrane Stroke Review Group trials register, Medline (from 1965), Embase (from 1980), BIDIS ISI (from ...
Stefano, Ricci +3 more
openaire +5 more sources
Piracetam for fetal distress in labour [PDF]
Piracetam is thought to promote the metabolism of brain cells when they are hypoxic. It has been used to prevent adverse effects of fetal distress.The objective of this review was to assess the effects of piracetam for suspected fetal distress in labour on method of delivery and perinatal morbidity.The Cochrane Pregnancy and Childbirth Group trials ...
G Justus, Hofmeyr, Regina, Kulier
openaire +4 more sources
Physiological disposition of oral piracetam in Sprague-Dawley rats
The distribution and fate of piracetam (2-oxo-1-pyrrolidine acetamide, Nootropil), the prototype ‘nootropic drug’, was examined in rats given 100–1000 mg kg−1 by gavage, with or without [3H]piracetam as a tracer.
Maria T Tacconi, Richard J Wurtman
core +1 more source
Stability of piracetam in solid pharmaceutical forms [PDF]
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica MoldovaIntroducere. Formele farmaceutice solide (comprimatele, capsulele) sunt preferate pentru administrarea piracetamului (medicament nootrop).
Cereniuc, Alina +3 more
core
Synergy of piracetam and aminalon in the cerebroprotective effect of olatropyl.
Optimization of pharmacotherapy of neurological and psychosomatic diseases led to the creation of combined medicines containing two or more components with different mechanisms of action, differently affecting the pathogenesis and clinical ...
V. I. Mamchur, S. N. Dronov
doaj +1 more source

